Therapy Component Trips Up Lykos’ MDMA At US FDA AdComm For PTSD

 
• By Bridget Silverman
  
MDMA
Advisory committee members raised several concerns about Lykos' proposed "entactogen." • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers